ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 537

Differences and Associated Factors in General Disability and Hand Disability Between Patients with Rheumatoid Arthritis and Psoriatic Arthritis

Jose Andres Roman Ivorra1, Óscar Álvarez1, Jose Ivorra Cortes1, Javier Navarro Muñoz2, Elena Grau Garcia3, Luis Gonzalez Puig1, Inmaculada Chalmeta Verdejo1, Carlos Feced Olmos1, Eztizen Labrador Sanchez1, Francisco Miguel Ortiz-Sanjuán4, Karla Arevalo Ruales1, Rosa Negueroles Albuixech1, Jorge Fragio Gil1, Isabel Martinez Cordellat1, Jose Luis Valero Sanz1, Cristina Alcañiz Escandell1,3, Gema Poveda Marin1,3, Carmen Najera Herranz1 and Victoria Fornes Ferrer5, 1Department of Rheumatology, Hospital Universitario y Politecnico La Fe, Valencia, Spain, 2Universidad Católica de Valencia, Valencia, Spain, 3IIS La Fe, Valencia, Spain, 4Department of Rheumatology, Hospital Universitario y Politecnico La Fe, Santander, Spain, 5Biostatistics Unit. IIS La Fe, Valencia, Spain

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Disability, psoriatic arthritis and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2016

Title: Rheumatoid Arthritis – Clinical Aspects - Poster I: Clinical Characteristics/Presentation/Prognosis

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:   Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are well-known disabling conditions, with high impact on patients functioning and quality of life. However, little is published about the differences in disability between RA and PsA patients. The aim of this study was to evaluate and compare general functional disability and specific hand disability in patients with RA and PsA.

Methods:  A cross-sectional study was performed. Consecutive patients with RA and PsA attended in a hospital were selected and their medical records reviewed. Sociodemographic and clinical variables including disease duration and activity (DAS28), physical function (Health Assessment Questionnaire, HAQ), handgrip strength in both hands (using an isometric hand dynamometer), radiographic damage (modified Sharp/van der Heijde score (SHS)), and pharmacological treatments were collected following a standardized protocol. Descriptive and bivariate analyses were performed. Multivariate linear regression models completed were to assess disability associated factors.

Results are expressed as coefficient (coef) and 95% confidence interval (CI). Results:  A total of 103 RA patients (82.5% were women, mean disease duration 16 years, mean HAQ 1.29, mean DAS28 3.61, mean SHS 45.81, mean grip strength of the right hand 11.22, mean grip strengh of the left hand 11.02, 60.8% on biologic therapy) and 94 patients with PsA (82.5% were women, mean disease duration 14 years, mean HAQ 0.57, mean DAS28 2.7, mean SHS 7.8, mean grip strength of the right hand 20.79, mean grip strength of the left hand 20.06, 51,1% on biologic therapy) were analyzed. Compared to PsA, RA patients were significantly more active, presented more damage and worse grip strength in both hands. Slightly differences were found between disease in the disease duration (p=0,020). In the multivariate regression analyses, poorer function (HAQ score) was associated with RA (compared with PsA) coef=0.24 (95% CI 0.04-0.45), female sex coef=0.37 (95% CI 0.16-0.57), DAS28 coef=0.23 (95% CI 0.16-0.31), and SHS, but not with disease duration. The same results were obtained when the handgrip strength (in each hand separately) were entered in the regression models. 

Conclusion:   In our study RA patients presented more general and hand disability compared to PsA patients. Other factors as female sex are also associated with poorer function.


Disclosure: J. A. Roman Ivorra, None; Ó. Álvarez, None; J. Ivorra Cortes, None; J. Navarro Muñoz, None; E. Grau Garcia, None; L. Gonzalez Puig, None; I. Chalmeta Verdejo, None; C. Feced Olmos, None; E. Labrador Sanchez, None; F. M. Ortiz-Sanjuán, None; K. Arevalo Ruales, None; R. Negueroles Albuixech, None; J. Fragio Gil, None; I. Martinez Cordellat, None; J. L. Valero Sanz, None; C. Alcañiz Escandell, None; G. Poveda Marin, None; C. Najera Herranz, None; V. Fornes Ferrer, None.

To cite this abstract in AMA style:

Roman Ivorra JA, Álvarez Ó, Ivorra Cortes J, Navarro Muñoz J, Grau Garcia E, Gonzalez Puig L, Chalmeta Verdejo I, Feced Olmos C, Labrador Sanchez E, Ortiz-Sanjuán FM, Arevalo Ruales K, Negueroles Albuixech R, Fragio Gil J, Martinez Cordellat I, Valero Sanz JL, Alcañiz Escandell C, Poveda Marin G, Najera Herranz C, Fornes Ferrer V. Differences and Associated Factors in General Disability and Hand Disability Between Patients with Rheumatoid Arthritis and Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/differences-and-associated-factors-in-general-disability-and-hand-disability-between-patients-with-rheumatoid-arthritis-and-psoriatic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/differences-and-associated-factors-in-general-disability-and-hand-disability-between-patients-with-rheumatoid-arthritis-and-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology